Immunology of Infectious Disease News Volume 11.14 | Apr 12 2023

    0
    19








    2023-04-12 | IIDN 11.14


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 11.14 – 12 April, 2023
    TOP STORY

    A Bacterial Autotransporter Impairs Innate Immune Responses by Targeting the Transcription Factor TFE3

    By screening a library of enterohemorrhagic Escherichia coli mutants, scientists uncovered EhaF, an uncharacterized protein, as an inhibitor of innate immune responses including type I interferons.
    [Nature Communications]

    Full Article
    PUBLICATIONSRanked by the impact factor of the journal

    An Intranasal Influenza Virus-Vectored Vaccine Prevents SARS-CoV-2 Replication in Respiratory Tissues of Mice and Hamsters

    Researchers developed an intranasal vaccine candidate based on a live attenuated influenza virus with a deleted NS1 gene that encodes cell surface expression of the receptor-binding-domain of the SARS-CoV-2 spike protein.
    [Nature Communications]

    Full Article

    Enhanced Inhibition of MHC-I Expression by SARS-CoV-2 Omicron Subvariants

    The authors demonstrated that all SARS-CoV-2 variants of concern possessed the ability to suppress major histocompatibility complex class I (MHC-I) expression.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Full ArticlePress Release

    SARS-CoV-2 Evolved Variants Optimize Binding to Cellular Glycocalyx

    Researchers investigated the effect of an evolving spike positive charge in SARS-CoV-2 variants and subsequent interactions with heparan sulfate and the ACE2 in the glycocalyx.
    [Cell Reports Physical Science]

    Full ArticleGraphical Abstract

    Cell Culture Systems for Isolation of SARS-CoV-2 Clinical Isolates and Generation of Recombinant Virus

    Scientists generated a panel of 17 human cell lines overexpressing SARS-CoV-2 entry factors and tested their ability to support viral infection.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    Germline-Targeting HIV-1 Env Vaccination Induces VRC01-Class Antibodies with Rare Insertions

    The authors described a BG505 SOSIP trimer, termed GT1.2, to optimize binding to gl-CH31, the unmutated common precursor of the CH30-34 broadly neutralizing antibody lineage that acquired a large CDRH1 insertion.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract

    Phosphatidylserine-Positive Extracellular Vesicles Boost Effector CD8+ T Cell Responses during Viral Infection

    Investigators showed that extracellular vesicle (EV)+ cell abundance increased during viral infection and that EVs preferentially bound to activated, but not naive, CD8+ T cells.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Full Article

    PYHIN Protein IFI207 Regulates Cytokine Transcription and IRF7 and Contributes to the Establishment of K. pneumoniae Infection

    Researchers characterized mouse PYHIN IFI207, which they found was not involved in DNA sensing but rather was required for cytokine promoter induction in macrophages.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Transforming Growth Factor β Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4+ T Cells

    Using a serum-free in vitro system, scientists further delineated the role of TGF-β signaling in mediating HIV-1 infection of activated and resting memory CD4+ T cells.
    [Journal of Virology]

    Abstract

    Polymyxin B Inhibits Pro-Inflammatory Effects of E. coli Outer Membrane Vesicles Whilst Increasing Immune Cell Uptake and Clearance

    Investigators assessed the ability of Polymyxin B to neutralize the immune-stimulatory properties of outer membrane vesicles (OMVs) whilst modulating the uptake of OMVs in human immune cells.
    [Journal of Antibiotics]

    Full Article
    Breakthroughs take time. Isolating the right cells shouldn't. Learn more.
    REVIEWS

    Mycobacterium tuberculosis and SARS-CoV-2 Co-Infections: The Knowns and Unknowns

    The authors highlight dysregulated immune responses induced by SARS-CoV-2 and Mtb, their potential interplay, and implications for co-infection in the lungs.
    [iScience]

    AbstractFull ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Biden Ends COVID National Emergency after Congress Acts

    The US national emergency to respond to the COVID-19 pandemic ended Monday as President Joe Biden signed a bipartisan congressional resolution to bring it to a close after three years.
    [The Associated Press]

    Press Release
    FEATURED EVENT

    IPAC Canada 2023 National Education Conference

    May 28 – 31, 2023
    Vancouver, British Columbia, Canada

    > See All Events

    JOB OPPORTUNITIES

    Director – National Institute of Infectious Diseases and Vaccinology

    National Health Research Institutes – Zhunan, Taiwan

    Postdoctoral Appointee – Virology/Immunology and Antiviral Therapies

    Sandia National Laboratories – Livermore, California, United States

    Postdoctoral Fellow – Herpesvirus Vaccine Development

    The Beckman Research Institute of City of Hope – Duarte, California, United States

    Principal Scientist – Leukocyte-Tissue Interface

    Pfizer, Inc.- Cambridge, Massachusetts, United States

    Centre Head – Innate Immunity and Infectious Diseases

    Hudson Institute of Medical Research – Melbourne, Australia

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immunology of Infectious Disease News Twitter